GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,448.50p
   
  • Change Today:
    -14.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,109.73m
  • Volume: 7,903,960
  • Market Cap: £59,530m
  • RiskGrade: 129

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
30-Apr-25 Shore Capital Buy 1,483.50p - - Reiteration
28-Mar-25 JP Morgan Cazenove Underweight 1,488.50p - - Reiteration
07-Jan-25 JP Morgan Cazenove Underweight 1,357.50p - - Reiteration
11-Dec-24 JP Morgan Cazenove Underweight 1,340.50p - - Reiteration
29-Nov-24 Berenberg Bank Buy 1,335.00p 1,820.00p 1,600.00p Reiteration
10-Sep-24 Berenberg Bank Buy 1,671.00p - 1,820.00p Reiteration
03-Sep-24 Deutsche Buy 1,655.00p - 1,850.00p Reiteration
28-Aug-24 Shore Capital Buy 1,651.50p - - Reiteration
16-Aug-24 Shore Capital Buy 1,591.00p - - Reiteration
14-Aug-24 Berenberg Bank Buy 1,597.50p - 1,820.00p Reiteration
31-Jul-24 Deutsche Buy 1,512.00p 1,950.00p 1,850.00p Reiteration
29-Jul-24 JP Morgan Cazenove Underweight 1,557.00p - - Reiteration
05-Jul-24 Citigroup Buy 1,511.00p 2,120.00p 1,900.00p Reiteration
02-Jul-24 JP Morgan Cazenove Underweight 1,503.50p - - Reiteration
28-Jun-24 Deutsche Buy 1,529.50p - 1,950.00p Reiteration
27-Jun-24 Jefferies Buy 1,526.00p - 2,100.00p Reiteration
27-Jun-24 Shore Capital Buy 1,526.00p - - Reiteration
24-Jun-24 Citigroup Buy 1,608.50p - 2,100.00p Reiteration
18-Jun-24 JP Morgan Cazenove Underweight 1,612.00p - - Reiteration
18-Jun-24 Deutsche Buy 1,612.00p - 1,950.00p Reiteration
12-Jun-24 Shore Capital Buy 1,605.00p - - Reiteration
04-Jun-24 JP Morgan Cazenove Underweight 1,615.00p - - Reiteration
07-May-24 Barclays Equal-weight 1,761.00p - 1,725.00p Reiteration
02-May-24 JP Morgan Cazenove Underweight 1,728.50p 1,530.00p 1,660.00p Reiteration
01-May-24 Shore Capital Buy 1,705.00p - - Reiteration
17-Apr-24 Deutsche Buy 1,590.00p - 1,950.00p Reiteration
08-Apr-24 Barclays Equal-weight 1,620.00p - 1,725.00p Reiteration
12-Mar-24 Deutsche Buy 1,685.20p - 1,950.00p Reiteration
07-Mar-24 Shore Capital Buy 1,711.20p - - Reiteration
27-Feb-24 Deutsche Buy 1,671.00p - 1,950.00p Reiteration
15-Feb-24 Shore Capital Buy 1,663.00p - - Reiteration
14-Feb-24 Berenberg Bank Buy 1,668.00p 1,650.00p 1,820.00p Reiteration
09-Feb-24 Barclays Buy 1,660.00p - 1,950.00p Reiteration
31-Jan-24 Shore Capital Buy 1,568.00p - - Reiteration
18-Dec-23 Barclays Equal-weight 1,442.60p - 1,575.00p Reiteration
28-Nov-23 Citigroup Neutral 1,411.80p - - Reiteration
24-Nov-23 Berenberg Bank Buy 1,422.60p - 1,650.00p Reiteration
06-Nov-23 Barclays Equal-weight 1,405.00p - 1,575.00p Reiteration
11-Oct-23 Shore Capital Buy 1,519.20p - - Reiteration
03-Oct-23 Deutsche Buy 1,485.20p - - Reiteration
02-Oct-23 Citigroup Neutral 1,484.00p - - Reiteration
29-Sep-23 JP Morgan Cazenove Underweight 1,492.00p - - Reiteration
08-Sep-23 JP Morgan Cazenove Underweight 1,444.20p - - Reiteration
05-Sep-23 Deutsche Buy 1,381.40p - 1,700.00p Reiteration
04-Sep-23 Barclays Equal-weight 1,373.60p - 1,450.00p Reiteration
28-Jul-23 Berenberg Bank Buy 1,383.00p - 1,730.00p Reiteration
20-Jul-23 JP Morgan Cazenove Underweight 1,387.20p - - Reiteration
26-Jun-23 Citigroup Neutral 1,419.80p - 1,700.00p Reiteration
26-Jun-23 Jefferies Hold 1,419.80p - 1,575.00p Reiteration
16-Jun-23 Shore Capital Buy 1,364.60p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

GSK Market Data

Currency UK Pounds
Share Price 1,448.50p
Change Today -14.50p
% Change -0.99 %
52 Week High 1,812.50p
52 Week Low 1,264.00p
Volume 7,903,960
Shares Issued 4,109.73m
Market Cap £59,530m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.86% below the market average40.86% below the market average40.86% below the market average40.86% below the market average40.86% below the market average
4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average
Price Trend
21.07% above the market average21.07% above the market average21.07% above the market average21.07% above the market average21.07% above the market average
54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average
Income
70.61% above the market average70.61% above the market average70.61% above the market average70.61% above the market average70.61% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 15
Sell 3
Strong Sell 1
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 02-May-2025

Time Volume / Share Price
15:56 0 @ 1,459.00p
15:55 0 @ 1,459.00p
15:55 0 @ 1,459.00p
17:03 137,045 @ 1,455.00p
15:21 0 @ 1,453.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page